Clinical trial Recruiting at 1 site Interventional Ages 18 and up

Knee joint fluid changes after genicular artery embolization for osteoarthritis

Official title: Genicular Artery Embolization for Knee Osteoarthritis: Evaluation of the Correlation Between Subjective Symptom Response and Objective Measures of Inflammation

Run by University of Colorado, Denver · NCT06940479 · Data updated 2026-11-12

This project will test whether genicular artery embolization (GAE) can reduce knee pain and joint inflammation in adults with knee osteoarthritis by comparing knee fluid samples, MRI scans, performance tests, and symptoms before and after the procedure.

Quick facts

Study typeInterventional
Ages18 Years and up
SexAll
Enrollment46 (estimated)
SponsorUniversity of Colorado, Denver
Academic / other
Locations1 site (Aurora, Colorado)
StatusRecruiting
StartedJuly 16, 2025
Main results expectedJuly 2027
Study endsJuly 2028
Registry record updatedMarch 24, 2026
Trial IDNCT06940479 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Adults aged 18 or older with knee osteoarthritis (Kellgren-Lawrence grade 1–3), persistent moderate-to-severe pain despite conservative therapy, BMI under 35, and a planned GAE procedure are ideal candidates.

Probably not a fit

Patients with very advanced osteoarthritis (KL grade 4), active knee infection, uncorrected bleeding disorders, or who cannot safely stop anticoagulation are unlikely to benefit from this procedure or participation.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

Adults with radiographic knee osteoarthritis who are scheduled for genicular artery embolization will have synovial fluid collected, contrast-enhanced MRI scans, performance-based measures, and questionnaires before and after the procedure. Researchers will compare inflammatory markers and other changes in the synovial fluid alongside imaging and clinical outcomes to see if GAE corresponds with reduced inflammation and pain. The intervention is a single-site, interventional procedure performed at the University of Colorado Anschutz Medical Campus. Follow-up measures are taken after the procedure to assess short-term biological and symptomatic changes.

Why it matters

Potential benefit: If successful, GAE could lower knee pain and joint inflammation and potentially delay or reduce the need for more invasive surgery.

How similar studies have gone: Small case series and early clinical reports of GAE have reported pain relief, but pre- and post-procedure synovial fluid comparisons are a relatively novel approach.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* Age ≥ 18 years
* Planned to undergo genicular artery embolization to treat knee osteoarthritis.
* Osteoarthritis on knee radiograph (Kellgren-Lawrence score 1-3) within the last 6 months
* Persistent moderate to severe knee pain (visual analog scale \[VAS\] \>3) for at least 6 months
* Pain refractory or intolerant to conservative therapies (e.g. analgesia, exercise, weight-loss, joint injections, physical therapy)
* BMI \< 35 kg / m2
* Stated willingness to comply with study procedures and availability for the duration of the study

Exclusion Criteria:

* Coagulation disturbances not normalized by medical treatment (INR \>1.8 and platelets \<50 x 10\^9/L)
* Receiving medications for anticoagulation which cannot safely be held for the procedure (e.g ASA for 5 days, Lovenox for 24 hours, Eliquis for 4-6 days depending on creatinine clearance
* Allergy to iodinated contrast agents not responsive to steroid premedication regimen
* Active knee joint infection
* Acute knee injury with surgical indication (MRI evidence of acute fracture or ligamentous injury of the knee)
* Prior total or partial knee replacement in the subject knee
* Intra-articular steroid injection within 2 months
* Untreated lower extremity vascular arterial disease
* Untreated venous insufficiency
* Presence of medical condition with life expectancy less than 6 months
* Patients who have undergone previous lower extremity embolization
* Patients with renal insufficiency based on an estimated GFR\<45 ml/min who are not already on hemodialysis
* Patients who are pregnant or intend to become pregnant within 6 months of the procedure
* American Society of Anesthesiologists classification \> 3
* Less than 3 mm of synovial fluid in the lateral suprapatellar recess on MRI or US

Where it's running

  • University of Colorado Anschutz Medical Campus
    Aurora, Colorado, United States
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.